Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
7.06
+0.48 (7.29%)
Jan 22, 2026, 4:00 PM EST - Market closed
Inventiva Market Cap
Inventiva has a market cap or net worth of $1.28 billion as of January 22, 2026. Its market cap has increased by 513.78% in one year.
Market Cap
1.28B
Enterprise Value
1.29B
1-Year Change
513.78%
Ranking
Category
Stock Price
$7.06
Market Cap Chart
Since October 26, 2018, Inventiva's market cap has increased from $151.00M to $1.28B, an increase of 748.76%. That is a compound annual growth rate of 34.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 1.23B | 39.38% |
| Dec 31, 2025 | 884.84M | 309.83% |
| Dec 31, 2024 | 215.91M | -7.64% |
| Dec 29, 2023 | 233.77M | 16.05% |
| Dec 30, 2022 | 201.44M | -63.07% |
| Dec 31, 2021 | 545.53M | -0.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EyePoint | 1.29B |
| AbCellera Biologics | 1.28B |
| Sana Biotechnology | 1.27B |
| Xeris Biopharma Holdings | 1.26B |
| Rapport Therapeutics | 1.26B |
| Capricor Therapeutics | 1.26B |
| Day One Biopharmaceuticals | 1.24B |
| Pharming Group | 1.22B |